Healthcare / Medical Care FacilitiesHKSE
$0.22
+0.01 (+2.37%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $206.1M · quality 59.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
40/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.5B
P/E
102.9x
↑EV/EBITDA
1.7x
↓ROE
0.5%
↑Gross Margin
26.0%
↓Debt/Equity
0.05
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+5.2%
FCF CAGR
+181.0%
FCF margin
7.2%
FCF / Net income
8.99x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.79B · net income $14.4M · FCF $129.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.79B | $1.79B | $1.83B | $1.83B | $1.54B |
| Net Income | $14.4M | $14.4M | $-203.7M | $-194.2M | $15.3M |
| EBITDA | $247.9M | $247.9M | $35.5M | $48.2M | $222.7M |
| EPS | 0.00 | 0.00 | -0.03 | -0.03 | 0.00 |
| Gross Margin | 26.0% | 26.0% | 26.6% | 27.4% | 27.0% |
| Operating Margin | 4.4% | 4.4% | 4.6% | 5.6% | 1.6% |
| Net Margin | 0.8% | 0.8% | -11.1% | -10.6% | 1.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.05 | 0.05 | 0.11 | 0.14 | 0.14 |
| Current Ratio | 3.64 | 3.64 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $129.2M | $129.2M | $206.1M | $229.8M | $5.8M |
| Returns | |||||
| ROE | 0.5% | 0.5% | -6.8% | -6.0% | 0.4% |
| Valuation | |||||
| P/E | 102.86 | 102.86 | — | — | 171.43 |
| EV/EBITDA | 1.71 | 1.71 | 33.65 | 31.65 | 9.63 |
| P/B | 0.49 | 0.49 | 0.69 | 0.65 | 0.76 |
| Growth & Yield | |||||
| Revenue Growth | -2.6% | -2.6% | 0.0% | 19.4% | — |
| EPS Growth | 107.0% | 107.0% | -4.9% | -1466.7% | — |
| Dividend Yield | 0.8% | 0.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
109.0%
EPS terminal req.
$0.02
Spread vs growth
-2.0%
5Y implied EPS CAGR
61.7%
EPS terminal req.
$0.02
Spread vs growth
45.3%
10Y implied EPS CAGR
33.4%
EPS terminal req.
$0.04
Spread vs growth
73.6%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-8.4%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.03 → 0.00
Residual
-9.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.